TP53 and neoplasm: Gendicine is a non-replicative vector, where the E1 gene is replaced with the p53 cDNA gene. The expression of p53 in tumor cells stimulates the anticancer effect by triggering the apoptotic pathway and inhibiting damaged DNA repair.